Searched for
K ANJI REDDY
Dr Reddy’s top hand Alok Sonig quitsSonig handled challenging roles during his six-year tenure at the company founded and named after scientist-entrepreneur late K Anji Reddy.- Here's a snapshot of Sun Pharmaceutical's acquisitions and turnaround storiesExperts say there are three key tests — a substantial improvement opportunity, strategic fit for existing businesses and reasonable price.
- Is Sun Pharma founder Dilip Shanghvi readying a succession plan?Shanghvi, who recently steered the biggest acquisition in pharma sector by acquiring Ranbaxy, said in coming days he would like to focus on...
- Dr Reddy’s chief GV Prasad bemoans bureaucracy in companyDr Reddy’s Labs has not fully utilised its potential and must break the barriers of bureaucracy within the organisation, chairman of the co...
- K Anji Reddy, promoter and chairman Dr Reddy's Lab, passes awaySatish Reddy, his son is currently Managing Director and CEO of the company, while son-in-law G V Prasad is the Vice Chairman and the Chief...
- Dr Reddy's promoters transfer large holding to family-owned TrustThe promoters of pharmaceutical firm Dr Reddy's Laboratories have transferred shares from Dr Reddy's Holdings Limited (DRHL) to APS Trust, ...
- Dr Reddy's Laboratories' Anji Reddy skips AGM for first timeSpeculation on Dr Reddy's Laboratories' grand old founder Dr K Anji Reddy passing the baton to the senior management came alive at the comp...
- Growth rates may decline in next few years: Dr Reddy's LaboratoriesDr Reddy's Laboratories today said its growth rates are likely to decline in the next few years due to expiry of many of its patents.
- Dr Reddy's Laboratories bets big on biosimilars, eyes regulated marketsHyderabad-based Dr Reddy's Laboratories is betting big on the biosimilars segment and expects to enter developed markets soon.
- SEBI exempts Dr Reddy's promoters from open offerSEBI has exempted the promoters of Dr Reddy's from makingan open offer on account of transfer of nearly a fourth of co's equity holding amo...
- Dr Reddy's starts Phase-II trials of DRL-17822 moleculePhase-II clinical trials are conducted on a larger sample of human subjects (20-300) to assess how well a drug works.
- India and Russia will drive Dr Reddy’s growth : Dr K Anji ReddyIndia and Russia will drive growth for Dr Reddy’s Laboratories in the coming years, Dr K Anji Reddy told shareholders.
- Dr Reddy's aim at $1 bn revenue per year in next 3 yearsPharma major Dr Reddy's Laboratories aims to earn revenue of $ 1 billion per year from branded generics for the next three years, said K. A...
- Dr Reddy's to restructure German subsi BetapharmPharma major Dr Reddy's Laboratories (DRL) on Friday said it was restructuring German subsidiary Betapharm for better results in the future.
- No plan to sell domestic formulations business: Dr Reddy'sPharma major Dr Reddy's Laboratories Ltd (DRL) on Friday said it was restructuring German subsidiary Betapharm for better results in future...
- Dr Reddy’s eyes new ops for Perlecan candidatesDrug-maker Dr Reddy’s Laboratories will stop innovative drug research at Perlecan Pharma, its wholly-owned subsidiary, due to a virtual fre...
- DRL promoters may hike holdingDrugmaker Dr Reddy’s Laboratories founder and chairman K Anji Reddy on Monday said he was looking at raising promoter holding in the compan...
- Three cheers to the job that pays!Indira Nooyi was said to have earned a higher salary than Warren Buffet. UP CM Mayawati however, earns just as much. World news, events in ...
- DRL’s anti-diabetes drug to hit market by ’11Dr Reddy’s anti-diabetes molecule Balaglitazone, which has entered the final phase of clinical development, is expected to hit the world ma...
- Sinha to meet industrialists on BudgetFINANCE minister Yashwant Sinha is slated to meet a group of industrialists for pre-budget consultations early next week. An annual feature...
Load More
